The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...

The proof-of-concept study is one of the first to combine B and T cell analysis and potentially paves the way for tests that ...

Creative Diagnostics introduces comprehensive Vaccine Development CRO Services. NEW YORK, NY, UNITED STATES, February 22, 2025 /EINPresswir ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore been ...

Bluetongue virus risk is at a seasonal low, but producers should be ready for that to change in spring. Bluetongue virus is an insect-borne disease that ...

What is a viral vector? Viral vector vaccines use a version of a mild virus to safely deliver instructions in the form of genetic code to our body cells. These instructions enable your body to produce ...

EQS-News: GeoVax, Inc. / Key word (s): Financial Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification 19.02.2025 / 15:04 CET/CEST The issuer is solely responsible for the ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

IAVI said its Ebola Sudan vaccine candidate uses the same viral vector platform as Merck's single-dose Zaire Ebola virus vaccine. "Overall, it's a very similar vaccine, adapted for Sudan ...